BioCentury | Nov 14, 2011
Financial News

Kedem financial update

Global Health Ventures Inc. implemented a 1-for-20 reverse stock split, changed its name to Kedem Pharmaceuticals Inc. and began trading under the symbol "GHLVD." The company plans to change its symbol to "KDMP" on Dec....
BioCentury | Jul 11, 2011
Company News

Global Health Ventures management update

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Hired: Lola Maksumova as SVP and COO, formerly VP of drug development at Pacific Therapeutics Ltd. WIR Staff...
BioCentury | Feb 28, 2011
Clinical News

X-Excite: Phase I started

...X-Excite vs. Viagra sildenafil in 24 patients. Pfizer Inc. (NYSE:PFE, New York, N.Y.) markets Viagra. Global Health Ventures Inc....
BioCentury | Jun 28, 2010
Company News

Global Health Ventures, Pacific Therapeutics deal

...to treat intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Global Health Ventures Inc....
BioCentury | Jun 7, 2010
Financial News

Global Health Ventures financial update

...entered into a $20 million, 30-month equity purchase agreement with Lincoln Park Capital Fund LLC. Global Health Ventures Inc....
BioCentury | Apr 19, 2010
Financial News

Global Health Ventures completes private placement of units

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Date completed: 4/8/10 Type: Private placement of units Raised: $500,000 Units: 625,000 Price: $0.80 (unit) Shares after offering: 68.7 million Note: Each unit comprises a...
BioCentury | Nov 2, 2009
Financial News

Global Health Ventures completes private placement of units

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Date completed: 10/28/09 Type: Private placement of units Raised: $600,000 Units: 800,000 Price: $0.75 (unit) Shares after offering: 63.5 million Note: Each unit comprises a...
BioCentury | Mar 30, 2009
Company News

Globe Laboratories, Global Health Ventures deal

...Merchant bank Global Health Ventures received an exclusive, worldwide license to develop Globe's GL00901 for erectile dysfunction (ED...
...and is eligible for up to $10 million in milestones and less than 5% royalties. Global Health Ventures...
...after which it will seek to out-license the compound. Globe Laboratories Inc. , Vancouver, B.C. Global Health Ventures Inc....
BioCentury | Feb 2, 2009
Company News

Critical Pharmaceuticals, Global Health Ventures deal

...milestone payments and royalties. Further terms were not disclosed. Critical Pharmaceuticals Ltd. , Nottingham, U.K. Global Health Ventures Inc....
BioCentury | Jun 7, 2004
Politics, Policy & Law

BIO’s global health venture

The Biotechnology Industry Organization and the Gates Foundation are slated to announce on Monday the creation of a not-for-profit organization dedicated to facilitating the development and distribution of biotech products to treat diseases in the...
Items per page:
1 - 10 of 10
BioCentury | Nov 14, 2011
Financial News

Kedem financial update

Global Health Ventures Inc. implemented a 1-for-20 reverse stock split, changed its name to Kedem Pharmaceuticals Inc. and began trading under the symbol "GHLVD." The company plans to change its symbol to "KDMP" on Dec....
BioCentury | Jul 11, 2011
Company News

Global Health Ventures management update

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Hired: Lola Maksumova as SVP and COO, formerly VP of drug development at Pacific Therapeutics Ltd. WIR Staff...
BioCentury | Feb 28, 2011
Clinical News

X-Excite: Phase I started

...X-Excite vs. Viagra sildenafil in 24 patients. Pfizer Inc. (NYSE:PFE, New York, N.Y.) markets Viagra. Global Health Ventures Inc....
BioCentury | Jun 28, 2010
Company News

Global Health Ventures, Pacific Therapeutics deal

...to treat intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Global Health Ventures Inc....
BioCentury | Jun 7, 2010
Financial News

Global Health Ventures financial update

...entered into a $20 million, 30-month equity purchase agreement with Lincoln Park Capital Fund LLC. Global Health Ventures Inc....
BioCentury | Apr 19, 2010
Financial News

Global Health Ventures completes private placement of units

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Date completed: 4/8/10 Type: Private placement of units Raised: $500,000 Units: 625,000 Price: $0.80 (unit) Shares after offering: 68.7 million Note: Each unit comprises a...
BioCentury | Nov 2, 2009
Financial News

Global Health Ventures completes private placement of units

Global Health Ventures Inc. (OTCBB:GHLV), Vancouver, B.C. Business: Drug delivery Date completed: 10/28/09 Type: Private placement of units Raised: $600,000 Units: 800,000 Price: $0.75 (unit) Shares after offering: 63.5 million Note: Each unit comprises a...
BioCentury | Mar 30, 2009
Company News

Globe Laboratories, Global Health Ventures deal

...Merchant bank Global Health Ventures received an exclusive, worldwide license to develop Globe's GL00901 for erectile dysfunction (ED...
...and is eligible for up to $10 million in milestones and less than 5% royalties. Global Health Ventures...
...after which it will seek to out-license the compound. Globe Laboratories Inc. , Vancouver, B.C. Global Health Ventures Inc....
BioCentury | Feb 2, 2009
Company News

Critical Pharmaceuticals, Global Health Ventures deal

...milestone payments and royalties. Further terms were not disclosed. Critical Pharmaceuticals Ltd. , Nottingham, U.K. Global Health Ventures Inc....
BioCentury | Jun 7, 2004
Politics, Policy & Law

BIO’s global health venture

The Biotechnology Industry Organization and the Gates Foundation are slated to announce on Monday the creation of a not-for-profit organization dedicated to facilitating the development and distribution of biotech products to treat diseases in the...
Items per page:
1 - 10 of 10